George Mellick

Professor George Mellick is a faculty member at Griffith University, affiliated with the School of Environment and Science and the Department of Bioscience. He holds the rank of Professor and leads research in neurodegenerative diseases, particularly Parkinson’s. His roles include Head of School (2018–2022) and Deputy Director of the Griffith Institute for Drug Discovery (2013–2018). He is currently a member of the Institute for Biomedicine and Glycomics.

Education & Research Interests
Mellick’s research focuses on Parkinson’s disease mechanisms, genetics, and therapeutic interventions. He has extensive experience in drug discovery, natural product screening, and molecular biology. His work integrates clinical, genetic, and biochemical approaches to understand disease progression.

Grants & Collaborations
He has led multiple grants, including studies on Kir4.2 channel mechanisms ($176,460 MJFF grant), mitochondrial modulators, and Parkinson’s genetics. Collaborations include institutions like the Clem Jones Centre for Neurobiology and the Michael J. Fox Foundation.

Awards & Advocacy
A recipient of the National Teaching Award, Mellick is also Chair of Parkinson’s Australia, advocating for the Parkinson’s community. He retired from Parkinson’s Queensland after 22 years, serving as President for 9 years.

Labs & Teams
Affiliated with the Griffith Institute for Drug Discovery and the Institute for Biomedicine and Glycomics, he leads interdisciplinary teams exploring Parkinson’s pathogenesis and drug development.